HOPE JUSTUS: Open Payments
NPI 1427738764 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 44 payments from 11 companies in 2025. Trend: 2023 $132 · 2024 $801 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $282 |
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Lilly USA, LLC | 10 | $151 |
| Astellas Pharma US Inc | 2 | $61 |
| Exact Sciences Corporation | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: Ozempic, MOUNJARO, FARXIGA, AIRSUPRA, Veozah, Rybelsus, Wegovy, JARDIANCE.
Industry payments across SC — which companies pay providers there.
